다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lexeo Therapeutics Inc (LXEO)
Lexeo Therapeutics Inc (LXEO) 뉴스

LXEO

Lexeo Therapeutics (LXEO)

Lexeo Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LXEO

1

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	22:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/06/13	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/23	06:03	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/15	05:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/14	06:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/09	20:09	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/09	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/09	20:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/09	20:00	GlobeNewswire Inc.	Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/05/07	20:30	GlobeNewswire Inc.	Lexeo Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/04/22	20:30	GlobeNewswire Inc.	Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/04/16	20:30	GlobeNewswire Inc.	Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/14	05:22	GlobeNewswire Inc.	Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/12	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/12	05:09	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/11	22:29	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/11	20:42	GlobeNewswire Inc.	Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/03/11	20:30	GlobeNewswire Inc.	Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/02/07	07:58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/02/07	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/02/05	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/02/05	21:00	GlobeNewswire Inc.	Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments	NASDAQ:LXEO	Lexeo Therapeutics Inc
2024/01/03	21:00	GlobeNewswire Inc.	Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:LXEO	Lexeo Therapeutics Inc
2023/12/18	21:00	GlobeNewswire Inc.	Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)	NASDAQ:LXEO	Lexeo Therapeutics Inc
2023/12/11	21:00	GlobeNewswire Inc.	Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights	NASDAQ:LXEO	Lexeo Therapeutics Inc

검색 관련기사 보기:NASDAQ:LXEO

1

Bank of America

Health Care Select Sector

Financial Select Sector

American Express

JP Morgan Chase

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관